Aurealis Therapeutics is a Swiss-Nordic Cell and Gene Therapy Platform Company.
Our multi-target Bacterial Vector therapy platform, based on genetically modified lactic bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers - Cancers - Ovarian, Peritoneal
